Thrombosis and Hemostasis Biomarkers Market by Product (Analyzers and Reagents & Consumables), Test Location, Test Type, Application, End-use, Country, and Region: Industry Analysis, Market Size, Market Share, and Forecast from 2025-2032
|
Report ID
AV3677
|
Published Date
April 2025
|
Pages
378
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Thrombosis and Hemostasis Biomarkers Market was valued at USD 5,482 million in 2024, growing at a CAGR of 6.40% from 2025 to 2032.
Thrombosis and hemostasis biomarkers are laboratory indicators derived from components of the hemostatic system, including von Willebrand factor (vWF), fibrinogen, and D-dimer. These biomarkers play a crucial role in identifying specific diseases and understanding their pathophysiological effects, with a wide range of clinical applications. They are instrumental in assessing the risk and diagnosing conditions such as venous thromboembolism (VTE). Additionally, they help predict thrombotic events in lymphoma patients, monitor responses to chemotherapy in pancreatic cancer patients, and support more effective patient management strategies.
Thrombosis and Hemostasis Biomarkers Market- Market Dynamics
Ø Rising Demand for Personalized Medicine Drives Growth in Thrombosis and Hemostasis Biomarkers
The increasing demand for personalized medicine is expected to drive growth in the thrombosis and hemostasis biomarkers market. These biomarkers enable healthcare providers to develop tailored treatment plans that are more effective and safer for each individual. Personalized medicine focuses on customizing medical treatments based on an individual\'s unique genetic makeup and medical history. In this context, thrombosis and hemostasis biomarkers are valuable for identifying patients at a higher risk of blood clots. For instance, researchers at Japan\'s Tohoku University have identified a newly discovered combination of genetic markers that can help individuals with inflammatory bowel disease (IBD) reduce the risk of blood clotting complications. This condition currently affects up to 210,000 people in Japan.
Leveraging the potential of biomarkers and personalized medicine, the British Heart Foundation has allocated funding to revolutionize heart treatments. According to the foundation, this new investment in personalized medicine could transform heart care in four key areas: developing digital hearts to predict treatment outcomes, creating personalized pacemakers, using personalized medicine to prevent heart attacks and strokes, and predicting the impact of chemotherapy on heart health.
Thrombosis and Hemostasis Biomarkers Market- Segmentation Analysis:
The Global Thrombosis and Hemostasis Biomarkers Market is segmented into six categories: product, test location, test type, application, end-use, and region.
In the thrombosis and hemostasis biomarkers market, the reagents and consumables segment held a dominant share of 65.40% in 2022 and is projected to be the fastest-growing segment during the forecast period. This growth is driven by the increasing prevalence of bleeding and coagulation disorders, heightened demand for diagnostic tools, and continuous product innovations. For instance, in March 2019, HORIBA UK Ltd launched a specific D-dimer parameter, GDDi 2, applicable in the Yumizen G instrument range, enhancing diagnostic capabilities.
In terms of test location, clinical laboratory tests dominated the market in 2022, accounting for 62.17% of the share. These tests are crucial for identifying abnormalities in blood clotting processes, assessing severity, and guiding treatment decisions. The segment\'s expansion is further supported by increased investments in healthcare infrastructure, particularly in emerging economies. For example, India\'s government health expenditure rose from 1.15% to 1.28% of its GDP between 2013-14 and 2022, improving access to diagnostic services, including clinical laboratory tests.
Thrombosis and Hemostasis Biomarkers Market- Geographical Insights
The thrombosis and hemostasis biomarkers market is geographically divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, with further segmentation based on key business-driving countries within each region. In 2024, North America led the thrombosis and hemostasis biomarkers market, driven by the rising prevalence of thrombosis and hemostasis disorders, ongoing technological advancements, and continuous R&D efforts. For example, the annual incidence of Venous Thromboembolism (VTE) in the region is estimated to range from 104 to 183 cases per 100,000 people. Additionally, between 10% to 30% of patients in intensive care units in the U.S. develop disseminated intravascular coagulation (DIC). The increasing demand for personalized medicine and supportive government initiatives are further fueling the market in this region.
The Asia Pacific region is expected to experience the fastest growth in the thrombosis and hemostasis biomarker market during the forecast period. This growth is attributed to the presence of leading companies, substantial R&D investments, and the region’s growing geriatric population. Additionally, the rising prevalence of cardiovascular diseases and blood clotting disorders is driving market demand. In 2019, Asia Pacific accounted for 58% of the 18.6 million CVD deaths worldwide, underscoring the region’s critical role in global cardiovascular health. Favorable reimbursement policies for thrombosis and hemostasis biomarker testing are further bolstering the regional market.
Thrombosis and Hemostasis Biomarkers Market- Competitive Landscape:
The thrombosis and hemostasis biomarkers market is highly competitive, with several dominant players continuously innovating to improve diagnostic accuracy and patient outcomes. Key market leaders such as BioMérieux SA, F. Hoffmann-La Roche Ltd., Biomedica Diagnostics, Siemens Healthineers, and HORIBA Ltd. offer a wide range of biomarker tests for the early detection and management of thrombotic diseases. These companies focus heavily on enhancing product portfolios through R&D, improving assay sensitivity and specificity while ensuring regulatory compliance. The increasing incidence of cardiovascular diseases and the growing demand for personalized medicine are intensifying competition. To meet the evolving needs of healthcare providers and patients, companies are developing new biomarkers and integrated diagnostic platforms. For instance, in June 2024, HORIBA unveiled the Yumizen H550 compact hematology analyzer, which features ESR and CBC/Diff capabilities. The new model is targeted at small- to mid-throughput laboratories, offering cost-effective and adaptable hematology solutions for the thrombosis and hemostasis biomarkers market.
Recent Developments:
v March 2023: F. Hoffmann-La Roche Ltd. partnered with Eli Lilly and Company to advance the development of the Elecsys Amyloid Plasma Panel (EAPP). This collaboration aims to enhance Roche’s thrombosis and hemostasis biomarker portfolio.
v April 2024: Siemens Healthcare Private Limited and Sysmex Corporation began distributing a diverse portfolio of hemostasis testing products to laboratories in both the United States and Europe.
v April 2024: Haemonetics Corporation received FDA 510(k) clearance for its TEG 6s Hemostasis Analyzer System Assay Cartridge, expanding the company’s viscoelastic testing capacity with the TEG 6s platform.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø Abbott
Ø bioMérieux SA
Ø F. Hoffmann-La Roche Ltd.
Ø Biomedica Diagnostics
Ø Siemens Healthineers
Ø HORIBA Ltd.
Ø Werfen
Ø Quidel Corporation
Ø Diazyme Laboratories, Inc.
Ø Thermo Fisher Scientific, Inc.
Ø Others
GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
Ø Analyzers
Ø Reagents & Consumables
GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY TEST LOCATION- MARKET ANALYSIS, 2019 - 2032
Ø Point-of-Care Tests
Ø Clinical Laboratory Tests
GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
Ø D-Dimer
Ø Anti-Thrombin III
Ø Plasminogen
Ø Selectins
Ø Soluble Fibrin
Ø Factor VIII
Ø PT
Ø APTT
Ø Fibrinogen
Ø Others
GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Ø Deep Vein Thrombosis (DVT)
Ø Disseminated Intravascular Coagulation (DIC)
Ø Pulmonary Embolism (PE)
Ø Others
GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
Ø Hospitals & Clinics
Ø Diagnostic Centers
Ø Academic & Research Institutes
Ø Others
GLOBAL THROMBOSIS AND HEMOSTASIS BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o The U.S.
o Canada
Ø Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Ø Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Thrombosis and Hemostasis Biomarkers Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Thrombosis and Hemostasis Biomarkers Market Snippet by Product
2.1.2. Thrombosis and Hemostasis Biomarkers Market Snippet by Test Location
2.1.3. Thrombosis and Hemostasis Biomarkers Market Snippet by Test Type
2.1.4. Thrombosis and Hemostasis Biomarkers Market Snippet by Application
2.1.5. Thrombosis and Hemostasis Biomarkers Market Snippet by End-use
2.1.6. Thrombosis and Hemostasis Biomarkers Market Snippet by Country
2.1.7. Thrombosis and Hemostasis Biomarkers Market Snippet by Region
2.2. Competitive Insights
3. Thrombosis and Hemostasis Biomarkers Key Market Trends
3.1. Thrombosis and Hemostasis Biomarkers Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Thrombosis and Hemostasis Biomarkers Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Thrombosis and Hemostasis Biomarkers Market Opportunities
3.4. Thrombosis and Hemostasis Biomarkers Market Future Trends
4. Thrombosis and Hemostasis Biomarkers Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Thrombosis and Hemostasis Biomarkers Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Thrombosis and Hemostasis Biomarkers Market Landscape
6.1. Thrombosis and Hemostasis Biomarkers Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Thrombosis and Hemostasis Biomarkers Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Analyzers
7.1.3. Reagents & Consumables
8. Thrombosis and Hemostasis Biomarkers Market – By Test Location
8.1. Overview
8.1.1. Segment Share Analysis, By Test Location, 2024 & 2032 (%)
8.1.2. Point-of-Care Tests
8.1.3. Clinical Laboratory Tests
9. Thrombosis and Hemostasis Biomarkers Market – By Test Type
9.1. Overview
9.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
9.1.2. D-Dimer
9.1.3. Anti-Thrombin III
9.1.4. Plasminogen
9.1.5. Selectins
9.1.6. Soluble Fibrin
9.1.7. Factor VIII
9.1.8. PT
9.1.9. APTT
9.1.10. Fibrinogen
9.1.11. Others
10. Thrombosis and Hemostasis Biomarkers Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Deep Vein Thrombosis (DVT)
10.1.3. Disseminated Intravascular Coagulation (DIC)
10.1.4. Pulmonary Embolism (PE)
10.1.5. Others
11. Thrombosis and Hemostasis Biomarkers Market – By End-use
11.1. Overview
11.1.1. Segment Share Analysis, By End-use, 2024 & 2032 (%)
11.1.2. Hospitals & Clinics
11.1.3. Diagnostic Centers
11.1.4. Academic & Research Institutes
11.1.5. Others
12. Thrombosis and Hemostasis Biomarkers Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Thrombosis and Hemostasis Biomarkers Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Thrombosis and Hemostasis Biomarkers Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3.10. Italy
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.10.4. Italy Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.3.10.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.10.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.7. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3.11. United Kingdom
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.11.4. United Kingdom Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.3.11.5. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.11.6. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.7. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3.12. France
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.12.4. France Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.3.12.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.12.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.7. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3.13. Russia
12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.13.3. Russia Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.3.13.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.13.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.6. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3.14. Netherlands
12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.14.3. Netherlands Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.3.14.4. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.14.5. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.6. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3.16. Poland
12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.16.3. Poland Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.3.16.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.6. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.3.17. Rest of Europe
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.3.17.4. Rest of the Europe Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.3.17.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.7. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Thrombosis and Hemostasis Biomarkers Key Manufacturers in Asia Pacific
12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.5. Asia Pacific Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.4.6. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.7. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.8. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4.9. India
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.9.4. India Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.4.9.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.7. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4.10. China
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.10.4. China Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.4.10.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.10.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.7. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4.14. Thailand
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.14.4. Thailand Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.4.14.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.7. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4.15. Indonesia
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.15.4. Indonesia Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.4.15.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.15.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.7. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.5. Latin America
12.5.1. Overview
12.5.2. Thrombosis and Hemostasis Biomarkers Key Manufacturers in Latin America
12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.5. Latin America Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.5.6. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.7. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.8. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Thrombosis and Hemostasis Biomarkers Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Test Location, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Thrombosis and Hemostasis Biomarkers Industry
13.1. Competitive Dashboard
13.2. Company Profiles
13.2.1. Abbott
13.2.2. bioMérieux SA
13.2.3. F. Hoffmann-La Roche Ltd.
13.2.4. Biomedica Diagnostics
13.2.5. Siemens Healthineers
13.2.6. HORIBA Ltd.
13.2.7. Werfen
13.2.8. Quidel Corporation
13.2.9. Diazyme Laboratories, Inc.
13.2.10. Thermo Fisher Scientific, Inc.
13.2.11. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
